RT Journal Article
SR Electronic
T1 The Construction of Multi-ethnic Polygenic Risk Score using Transfer Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.08.22272114
DO 10.1101/2022.03.08.22272114
A1 Zhao, Zhangchen
A1 Fritsche, Lars G.
A1 Smith, Jennifer A.
A1 Mukherjee, Bhramar
A1 Lee, Seunggeun
YR 2022
UL http://medrxiv.org/content/early/2022/03/10/2022.03.08.22272114.abstract
AB As most existing genome-wide association studies (GWAS) were conducted in European ancestry cohorts and as the existing PRS models have limited transferability across ancestry groups, PRS research on non-European ancestry groups is negatively impacted. Here we propose a novel PRS method using transfer learning techniques. Our approach, TL-PRS, uses gradient descent to fine-tune the baseline PRS model from an ancestry group with large sample GWAS to the dataset of target ancestry. In our application of constructing PRS for the six quantitative and two dichotomous traits for 10,285 South Asian and 8,168 African ancestry individuals in UK Biobank, TL-PRS achieved up to 42% average relative improvement compared to the existing methods. Our approach increases the transferability of PRSs across ancestries and thereby helps reduce existing inequities in genetics research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been conducted using the UK Biobank Resource under application number 45227. We thank Biobank Japan (BBJ) for releasing the genome-wide association summary statistics. B.M is supported by NSF DMS1712933 and NIH R01HG008773. S.L.is supported by BP+ Program through NRF of Korea funded by the Ministry of Science and ICT (2020H1D3A2A03100666). Z.Z. is supported by NIH R01HG008773 and R01LM012535.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves human genetic data, which can be obtained from UK Biobank Resource (https://www.ukbiobank.ac.uk/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://www.ukbiobank.ac.uk/. https://www.ukbiobank.ac.uk/ http://jenger.riken.jp/en/result https://www.internationalgenome.org/